NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Free cash flow 2016–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.6MFY2024 · since FY2016: -$4.5M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.6M | +35.9% |
| FY2023 | -$4.1M | +22.0% |
| FY2022 | -$5.2M | +47.0% |
| FY2021 | -$9.8M | +2.2% |
| FY2020 | -$10.1M | -35.3% |
| FY2019 | -$7.4M | +5.2% |
| FY2018 | -$7.8M | — |
| FY2016 | -$4.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice